INFLIXIMAB (IFX) IN MODERATE TO SEVERE ULCERATIVE COLITIS (UC): COMPARISON BETWEEN SCHEDULED TREATMENT STRATEGY AND BRIDGE STRATEGY

被引：0
|
作者：
Sambuelli, Alicia M.
Bellicoso, Maricel I.
Goncalves, Silvina A.
Negreira, Silvia
Huernos, Sergio P.
Chavero, Paula
Carraro, Cecilia
Tirado, Pablo
Cabanne, Ana
Gil, Anibal H.
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)31579-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1944
引用
收藏
页码：S402 / S402
页数：1
相关论文
共 50 条
  • [1] Infliximab in moderate to severe ulcerative colitis: comparison between scheduled treatment strategy and bridge strategy
    Sambuelli, A.
    Bellicoso, M.
    Negreira, S.
    Goncalves, S.
    Huernos, S.
    Chavero, P.
    Tirado, P.
    Cabanne, A.
    Gil, A.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S378 - S379
  • [2] Infliximab, Azathioprine, or Infliximab plus Azathioprine for Treatment of Moderate to Severe Ulcerative Colitis: The UC Success Trial
    Panccione, Remo
    Ghosh, Subrata
    Middleton, Stephen
    Marquez, Juan R.
    Khalif, Igor
    Flint, Laurence
    van Hoogstraten, Hubert
    Zheng, Hanzhe
    Danese, Silvio
    Rutgeerts, Paul J.
    GASTROENTEROLOGY, 2011, 140 (05) : S134 - S134
  • [3] Successive Treatment with Cyclosporine and Infliximab in Severe Ulcerative Colitis (UC)
    Leblanc, Sarah
    Allez, Matthieu
    Seksik, Philippe
    Flourie, Bernard
    Peeters, Harald
    Dupas, Jean-Louis
    Bouguen, Guillaume
    Biroulet, Laurent Peyrin
    Bourreille, Arnaud
    Dewit, Olivier
    Bouhnik, Yoram
    Michetti, Pierre F.
    Chaussade, Stanislas
    de Saussure, Philippe
    Colombel, Jean-Frederic
    Lemann, Marc
    GASTROENTEROLOGY, 2009, 136 (05) : A88 - A88
  • [4] Predictive Factors for Colectomy in Severe Corticosteroid (CS) Refractory Ulcerative Colitis (UC) Treated With Infliximab (IFX)
    Sambuelli, Alicia
    Gil, Anibal H.
    Negreira, Silvia M.
    Huernos, Sergio P.
    Goncalves, Silvina A.
    Tirado, Pablo R.
    Bellicoso, Maricel I.
    Goncalves, Silvina A.
    Sautu, Arturo
    Rocca, Andres
    Rausch, Astrid
    Daniela, Milito A.
    Doldan, Ivan
    Tirado, Pablo R.
    Toro, Martin A.
    GASTROENTEROLOGY, 2012, 142 (05) : S362 - S362
  • [5] Infliximab (IFX) as Rescue Therapy in Acute Corticosteroid Resistant Ulcerative Colitis (UC)
    Sambuelli, Alicia M.
    Gil, Anibal H.
    Negreira, Silvia M.
    Huernos, Sergio P.
    Goncalves, Silvina A.
    Tirado, Pablo R.
    Bellicoso, Maricel I.
    Daniela, Milito A.
    Rausch, Astrid
    Toro, Martin A.
    GASTROENTEROLOGY, 2011, 140 (05) : S590 - S590
  • [6] Cost-Effectiveness of Infliximab Scheduled Maintenance Treatment for the Management of Patients With Moderate-to-Severe Ulcerative Colitis
    Monfared, Amir A. Tahami
    Feagan, Brian G.
    GASTROENTEROLOGY, 2013, 144 (05) : S637 - S637
  • [7] Comparison of Real-World Outcomes of Adalimumab (ADA) and Infliximab (IFX) for Patients With Ulcerative Colitis (UC) in the United States
    Sandborn, William
    Sakuraba, Atsushi
    Ozbay, A. Burak
    Sorg, Rachael A.
    Reichmann, William
    Chao, Jingdong
    Skup, Martha
    GASTROENTEROLOGY, 2015, 148 (04) : S272 - S272
  • [8] A model of the long-term cost effectiveness of scheduled maintenance treatment with infliximab for moderate-to-severe ulcerative colitis
    Tsai, H. H.
    Punekar, Y. S.
    Morris, J.
    Fortun, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (10) : 1230 - 1239
  • [9] Infliximab in the treatment of severe ulcerative colitis
    Jiménez, JM
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2004, 96 (02) : 89 - 93
  • [10] Infliximab Therapy for Children with Moderate to Severe Ulcerative Colitis: A Step-Up versus a Top-Down Strategy
    Kim, Mi Jin
    Kim, Eunsil
    Kang, Ben
    Choe, Yon Ho
    YONSEI MEDICAL JOURNAL, 2021, 62 (07) : 608 - 614
12345